HuGE Literature Finder
|
||
Records 1-100
|
Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancer.
International journal of cancer 2019 Jan 144 (2): 281-289. Li Jun-Yan, Jing Ruilin, Wei Hongyi, Wang Minghao, Xiaowei Qi, Liu Haoxi, Jian Liu, Ou Jiang-Hua, Jiang Wei-Hua, Tian Fu-Guo, Sheng Yuan, Li Heng-Yu, Xu Hong, Zhang Rui-Shan, Guan Ai-Hua, Liu Ke, Jiang Hong-Chuan, Ren Yu, He Jian-Jun, Huang Weiwei, Liao Ning, Cai Xiangjun, Ming Jia, Ling Rui, Xu Yan, Hu Chun-Yan, Zhang Jianguo, Guo Baoliang, Ouyang Lizhi, Shuai Ping, Liu Zhenzhen, Zhong Ling, Zeng Zhen, Zhang Ting, Xuan Zhaoling, Tan Xuanni, Liang Junbin, Pan Qinwen, Chen Li, Zhang Fan, Fan Lin-Jun, Zhang Yi, Yang Xinhua, BoLi Jing, Chen Chongjian, Jiang J |
|
Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancer.
Endocrine 2018 Sep . Alzahrani Ali S, Murugan Avaniyapuram Kannan, Qasem Ebtesam, Alswailem Meshael M, AlGhamdi Balgees, Moria Yosra, Al-Hindi Hin |
|
Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.
Breast cancer research : BCR 2018 Aug 20 (1): 87. Penkert Judith, Schmidt Gunnar, Hofmann Winfried, Schubert Stephanie, Schieck Maximilian, Auber Bernd, Ripperger Tim, Hackmann Karl, Sturm Marc, Prokisch Holger, Hille-Betz Ursula, Mark Dorothea, Illig Thomas, Schlegelberger Brigitte, Steinemann Dor |
|
Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer.
Genetics in medicine : official journal of the American College of Medical Genetics 2018 Jul . Yurgelun Matthew B, Chittenden Anu B, Morales-Oyarvide Vicente, Rubinson Douglas A, Dunne Richard F, Kozak Margaret M, Qian Zhi Rong, Welch Marisa W, Brais Lauren K, Da Silva Annacarolina, Bui Justin L, Yuan Chen, Li Tingting, Li Wanwan, Masuda Atsuhiro, Gu Mancang, Bullock Andrea J, Chang Daniel T, Clancy Thomas E, Linehan David C, Findeis-Hosey Jennifer J, Doyle Leona A, Thorner Aaron R, Ducar Matthew D, Wollison Bruce M, Khalaf Natalia, Perez Kimberly, Syngal Sapna, Aguirre Andrew J, Hahn William C, Meyerson Matthew L, Fuchs Charles S, Ogino Shuji, Hornick Jason L, Hezel Aram F, Koong Albert C, Nowak Jonathan A, Wolpin Brian |
|
Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer.
PLoS genetics 2018 Apr 14 (4): e1007355. Paulo Paula, Maia Sofia, Pinto Carla, Pinto Pedro, Monteiro Augusta, Peixoto Ana, Teixeira Manuel |
|
A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer.
The Prostate 2018 Mar . Wu Yishuo, Yu Hongjie, Zheng S Lilly, Na Rong, Mamawala Mufaddal, Landis Tricia, Wiley Kathleen, Petkewicz Jacqueline, Shah Sameep, Shi Zhuqing, Novakovic Kristian, McGuire Michael, Brendler Charles B, Ding Qiang, Helfand Brian T, Carter H Ballentine, Cooney Kathleen A, Isaacs William B, Xu Jianfe |
|
CHEK2 Germ Line Mutations are Lacking among Familial and Sporadic Breast Cancer Patients in Rwanda
Asian Pacific journal of cancer prevention : APJCP 2018 Feb 19 (2): 375-379. Habyarimana Thierry, Attaleb Mohammed, Mugenzi Pacifique, Mazarati Jean Baptiste, Bakri Youssef, El Mzibri Mohamm |
|
Identification and analysis of CHEK2 germline mutations in Chinese BRCA1/2-negative breast cancer patients.
Breast cancer research and treatment 2018 Jan . Fan Zhenhua, Ouyang Tao, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Lin Benyao, Xu Ye, Xie Yunt |
|
Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Nov 29 (11): 1381-1389. Ring Kari L, Bruegl Amanda S, Allen Brian A, Elkin Eric P, Singh Nanda, Hartman Anne-Renee, Daniels Molly S, Broaddus Russell |
|
Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.
Genetics in medicine : official journal of the American College of Medical Genetics 2016 Oct . Muranen Taru A, Greco Dario, Blomqvist Carl, Aittomäki Kristiina, Khan Sofia, Hogervorst Frans, Verhoef Senno, Pharoah Paul D P, Dunning Alison M, Shah Mitul, Luben Robert, Bojesen Stig E, Nordestgaard Børge G, Schoemaker Minouk, Swerdlow Anthony, García-Closas Montserrat, Figueroa Jonine, Dörk Thilo, Bogdanova Natalia V, Hall Per, Li Jingmei, Khusnutdinova Elza, Bermisheva Marina, Kristensen Vessela, Borresen-Dale Anne-Lise, Investigators Nbcs, Peto Julian, Dos Santos Silva Isabel, Couch Fergus J, Olson Janet E, Hillemans Peter, Park-Simon Tjoung-Won, Brauch Hiltrud, Hamann Ute, Burwinkel Barbara, Marme Frederik, Meindl Alfons, Schmutzler Rita K, Cox Angela, Cross Simon S, Sawyer Elinor J, Tomlinson Ian, Lambrechts Diether, Moisse Matthieu, Lindblom Annika, Margolin Sara, Hollestelle Antoinette, Martens John W M, Fasching Peter A, Beckmann Matthias W, Andrulis Irene L, Knight Julia A, Investigators kConFab/Aocs, Anton-Culver Hoda, Ziogas Argyrios, Giles Graham G, Milne Roger L, Brenner Hermann, Arndt Volker, Mannermaa Arto, Kosma Veli-Matti, Chang-Claude Jenny, Rudolph Anja, Devilee Peter, Seynaeve Caroline, Hopper John L, Southey Melissa C, John Esther M, Whittemore Alice S, Bolla Manjeet K, Wang Qin, Michailidou Kyriaki, Dennis Joe, Easton Douglas F, Schmidt Marjanka K, Nevanlinna He |
|
Breast cancer risk is similar for CHEK2 founder and non-founder mutation carriers.
Cancer genetics 2016 Sep 209 (9): 403-407. Leedom Tracey P, LaDuca Holly, McFarland Rachel, Li Shuwei, Dolinsky Jill S, Chao Elizabeth |
|
Gene panel sequencing in familial Breast/Ovarian Cancer patients identifies multiple novel mutations also in genes others than BRCA1/2.
International journal of cancer 2016 Sep . Kraus Cornelia, Hoyer Juliane, Vasileiou Georgia, Wunderle Marius, Lux Michael P, Fasching Peter A, Krumbiegel Mandy, Uebe Steffen, Reuter Miriam, Beckmann Matthias W, Reis And |
|
Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH.
Breast cancer research and treatment 2016 Aug . Hackmann Karl, Kuhlee Franziska, Betcheva-Krajcir Elitza, Kahlert Anne-Karin, Mackenroth Luisa, Klink Barbara, Di Donato Nataliya, Tzschach Andreas, Kast Karin, Wimberger Pauline, Schrock Evelin, Rump Andre |
|
Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Jun . Schmidt Marjanka K, Hogervorst Frans, van Hien Richard, Cornelissen Sten, Broeks Annegien, Adank Muriel A, Meijers Hanne, Waisfisz Quinten, Hollestelle Antoinette, Schutte Mieke, van den Ouweland Ans, Hooning Maartje, Andrulis Irene L, Anton-Culver Hoda, Antonenkova Natalia N, Antoniou Antonis C, Arndt Volker, Bermisheva Marina, Bogdanova Natalia V, Bolla Manjeet K, Brauch Hiltrud, Brenner Hermann, Brüning Thomas, Burwinkel Barbara, Chang-Claude Jenny, Chenevix-Trench Georgia, Couch Fergus J, Cox Angela, Cross Simon S, Czene Kamila, Dunning Alison M, Fasching Peter A, Figueroa Jonine, Fletcher Olivia, Flyger Henrik, Galle Eva, García-Closas Montserrat, Giles Graham G, Haeberle Lothar, Hall Per, Hillemanns Peter, Hopper John L, Jakubowska Anna, John Esther M, Jones Michael, Khusnutdinova Elza, Knight Julia A, Kosma Veli-Matti, Kristensen Vessela, Lee Andrew, Lindblom Annika, Lubinski Jan, Mannermaa Arto, Margolin Sara, Meindl Alfons, Milne Roger L, Muranen Taru A, Newcomb Polly A, Offit Kenneth, Park-Simon Tjoung-Won, Peto Julian, Pharoah Paul D P, Robson Mark, Rudolph Anja, Sawyer Elinor J, Schmutzler Rita K, Seynaeve Caroline, Soens Julie, Southey Melissa C, Spurdle Amanda B, Surowy Harald, Swerdlow Anthony, Tollenaar Rob A E M, Tomlinson Ian, Trentham-Dietz Amy, Vachon Celine, Wang Qin, Whittemore Alice S, Ziogas Argyrios, van der Kolk Lizet, Nevanlinna Heli, Dörk Thilo, Bojesen Stig, Easton Douglas |
|
Germline variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms.
Blood 2016 Jun . Hinds David A, Barnholt Kimberly E, Mesa Ruben A, Kiefer Amy K, Do Chuong B, Eriksson Nicholas, Mountain Joanna L, Francke Uta, Tung Joyce Y, Nguyen Huong Marie, Zhang Haiyu, Gojenola Linda, Zehnder James L, Gotlib Jas |
|
Impact of SNPs on CpG Islands in the MYC and HRAS oncogenes and in a wide variety of tumor suppressor genes: a multi-cancer approach.
Cell cycle (Georgetown, Tex.) 2016 Apr 0. Samy Mohammad D, Yavorski John M, Mauro James A, Blanck Geor |
|
Do founder mutations characteristic of some cancer sites also predispose to pancreatic cancer?
International journal of cancer 2016 Mar . Lener Marcin R, Scott Rodney J, Klu?niak Wojciech, Baszuk Piotr, Cybulski Cezary, Wiechowska-Koz?owska Anna, Huzarski Tomasz, Byrski Tomasz, K?adny Józef, Pietrzak Sandra, Soluch Agnieszka, Jakubowska Anna, Lubi?ski J |
|
Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression.
Oncotarget 2016 Mar . Lasorsa Vito Alessandro, Formicola Daniela, Pignataro Piero, Cimmino Flora, Calabrese Francesco Maria, Mora Jaume, Esposito Maria Rosaria, Pantile Marcella, Zanon Carlo, De Mariano Marilena, Longo Luca, Hogarty Michael D, de Torres Carmen, Tonini Gian Paolo, Iolascon Achille, Capasso Mar |
|
Increased Risk for Other Cancers in Addition to Breast Cancer for CHEK2*1100delC Heterozygotes Estimated From the Copenhagen General Population Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Feb . Näslund-Koch Charlotte, Nordestgaard Børge G, Bojesen Stig |
|
A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer.
BMC medical genomics 2016 9 (1): 19. Mucaki Eliseos J, Caminsky Natasha G, Perri Ami M, Lu Ruipeng, Laederach Alain, Halvorsen Matthew, Knoll Joan H M, Rogan Peter |
|
Novel Nonsense Variants c.58C>T (p.Q20X) and c.256G>T (p.E85X) in the CHEK2 Gene Identified dentified in Breast Cancer Patients from Balochistan.
Asian Pacific journal of cancer prevention : APJCP 2016 17 (3): 1089-92. Baloch Abdul Hameed, Khosa Ahmad Nawaz, Bangulzai Nasrullah, Shuja Jamila, Naseeb Hafiz Khush, Jan Mohammad, Marghazani Illahi Bakhsh, Kakar Masood-Ul-Haq, Baloch Dost Mohammad, Cheema Abdul Majeed, Ahmad Jam |
|
Contribution of rare germline copy number variations and common susceptibility loci in Lynch Syndrome patients negative for mutations in the mismatch repair genes.
International journal of cancer. Journal international du cancer 2015 Dec . Villacis Rolando A R, Miranda Priscila M, Gomy Israel, Santos Erika M M, Carraro Dirce M, Achatz Maria I, Rossi Benedito M, Rogatto Silvia |
|
Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia.
Cancer 2015 Dec . Churpek Jane E, Marquez Rafael, Neistadt Barbara, Claussen Kimberly, Lee Ming K, Churpek Matthew M, Huo Dezheng, Weiner Howard, Bannerjee Mekhala, Godley Lucy A, Le Beau Michelle M, Pritchard Colin C, Walsh Tom, King Mary-Claire, Olopade Olufunmilayo I, Larson Richard |
|
Genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.
Expert review of anticancer therapy 2015 Nov 1-12. Lerner-Ellis Jordan, Khalouei Sam, Sopik Victoria, Narod Steven |
|
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
The New England journal of medicine 2015 Oct 373 (18): 1697-708. Mateo Joaquin, Carreira Suzanne, Sandhu Shahneen, Miranda Susana, Mossop Helen, Perez-Lopez Raquel, Nava Rodrigues Daniel, Robinson Dan, Omlin Aurelius, Tunariu Nina, Boysen Gunther, Porta Nuria, Flohr Penny, Gillman Alexa, Figueiredo Ines, Paulding Claire, Seed George, Jain Suneil, Ralph Christy, Protheroe Andrew, Hussain Syed, Jones Robert, Elliott Tony, McGovern Ursula, Bianchini Diletta, Goodall Jane, Zafeiriou Zafeiris, Williamson Chris T, Ferraldeschi Roberta, Riisnaes Ruth, Ebbs Bernardette, Fowler Gemma, Roda Desamparados, Yuan Wei, Wu Yi-Mi, Cao Xuhong, Brough Rachel, Pemberton Helen, A'Hern Roger, Swain Amanda, Kunju Lakshmi P, Eeles Rosalind, Attard Gerhardt, Lord Christopher J, Ashworth Alan, Rubin Mark A, Knudsen Karen E, Feng Felix Y, Chinnaiyan Arul M, Hall Emma, de Bono Johann |
|
Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland.
Clinical genetics 2015 Oct 88 (4): 366-70. Cybulski C, Lubi?ski J, Woko?orczyk D, Ku?niak W, Kashyap A, Sopik V, Huzarski T, Gronwald J, Byrski T, Szwiec M, Jakubowska A, Górski B, D?bniak T, Narod S A, Akbari M |
|
Prevalence of pathogenic mutations in cancer predisposition genes among pancreatic cancer patients.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015 Oct . Hu Chunling, Hart Steven N, Bamlet William R, Moore Raymond M, Nandakumar Kannabiran, Eckloff Bruce W, Lee Yean K, Petersen Gloria M, McWilliams Robert R, Couch Fergus |
|
Rapid Detection Method for the Four Most Common CHEK2 Mutations Based on Melting Profile Analysis.
Molecular diagnosis & therapy 2015 Oct . Borun Pawel, Salanowski Kacper, Godlewski Dariusz, Walkowiak Jaroslaw, Plawski Andrz |
|
CHEK2 mutations and the risk of papillary thyroid cancer.
International journal of cancer. Journal international du cancer 2015 Aug 137 (3): 548-52. Sio?ek Monika, Cybulski Cezary, G?sior-Perczak Danuta, Kowalik Artur, Kozak-Klonowska Beata, Kowalska Aldona, Ch?opek Ma?gorzata, Klu?niak Wojciech, Woko?orczyk Dominika, Pa?yga Iwona, Walczyk Agnieszka, Lizis-Kolus Katarzyna, Sun Ping, Lubi?ski Jan, Narod Steven A, Gó?d? Stanis? |
|
Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer.
Genetics in medicine : official journal of the American College of Medical Genetics 2015 Aug 17 (8): 630-8. Maxwell Kara N, Wubbenhorst Bradley, D'Andrea Kurt, Garman Bradley, Long Jessica M, Powers Jacquelyn, Rathbun Katherine, Stopfer Jill E, Zhu Jiajun, Bradbury Angela R, Simon Michael S, DeMichele Angela, Domchek Susan M, Nathanson Katherine |
|
Candidate gene analysis of BRCA1/2 mutation-negative high-risk Russian breast cancer patients.
Cancer letters 2015 Apr 359 (2): 259-61. Sokolenko Anna P, Preobrazhenskaya Elena V, Aleksakhina Svetlana N, Iyevleva Aglaya G, Mitiushkina Natalia V, Zaitseva Olga A, Yatsuk Olga S, Tiurin Vladislav I, Strelkova Tatiana N, Togo Alexandr V, Imyanitov Evgeny |
|
CHEK2 c.1100delC allele is rarely identified in Greek breast cancer cases.
Cancer genetics 2015 Apr 208 (4): 129-34. Apostolou Paraskevi, Fostira Florentia, Papamentzelopoulou Myrto, Michelli Maria, Panopoulos Christos, Fountzilas George, Konstantopoulou Irene, Voutsinas Gerassimos E, Yannoukakos Drakoul |
|
A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk.
Oncogene 2015 Jan . Wang N, Ding H, Liu C, Li X, Wei L, Yu J, Liu M, Ying M, Gao W, Jiang H, Wang |
|
Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Cancer 2015 Jan 121 (1): 25-33. Tung Nadine, Battelli Chiara, Allen Brian, Kaldate Rajesh, Bhatnagar Satish, Bowles Karla, Timms Kirsten, Garber Judy E, Herold Christina, Ellisen Leif, Krejdovsky Jill, DeLeonardis Kim, Sedgwick Kristin, Soltis Kathleen, Roa Benjamin, Wenstrup Richard J, Hartman Anne-Ren |
|
Inherited predisposition to breast cancer among African American women.
Breast cancer research and treatment 2015 Jan 149 (1): 31-9. Churpek Jane E, Walsh Tom, Zheng Yonglan, Moton Zakiya, Thornton Anne M, Lee Ming K, Casadei Silvia, Watts Amanda, Neistadt Barbara, Churpek Matthew M, Huo Dezheng, Zvosec Cecilia, Liu Fang, Niu Qun, Marquez Rafael, Zhang Jing, Fackenthal James, King Mary-Claire, Olopade Olufunmilayo |
|
Association between CHEK2 H371Y mutation and response to neoadjuvant chemotherapy in women with breast cancer.
BMC cancer 2015 15 194. Liu Yin, Xu Ye, Ouyang Tao, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Lin Benyao, Xie Yunt |
|
Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma.
PloS one 2015 10 (10): e0140819. Havranek Ondrej, Kleiblova Petra, Hojny Jan, Lhota Filip, Soucek Pavel, Trneny Marek, Kleibl Zden |
|
Genomic profiling of CHEK2*1100delC-mutated breast carcinomas.
BMC cancer 2015 15 877. Massink Maarten P G, Kooi Irsan E, Martens John W M, Waisfisz Quinten, Meijers-Heijboer Han |
|
Impact of alcohol dehydrogenase gene 4 polymorphisms on esophageal squamous cell carcinoma risk in a Chinese population.
PloS one 2015 10 (6): e0127304. Xu Xiaoling, Wang Jiwen, Zhu Shuang-Mei, Yang Ming, Fang Yun, Zhao An, Song Qian, Mao Weim |
|
Low prevalence of CHEK2 gene mutations in multiethnic cohorts of breast cancer patients in Malaysia.
PloS one 2015 10 (1): e0117104. Mohamad Suriati, Isa Nurismah Md, Muhammad Rohaizak, Emran Nor Aina, Kitan Nor Mayah, Kang Peter, Kang In Nee, Taib Nur Aishah Mohd, Teo Soo Hwang, Akmal Sharifah No |
|
Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers.
PloS one 2015 10 (6): e0130393. Domagala Pawel, Jakubowska Anna, Jaworska-Bieniek Katarzyna, Kaczmarek Katarzyna, Durda Katarzyna, Kurlapska Agnieszka, Cybulski Cezary, Lubinski J |
|
Breast cancer sensitivity to neoadjuvant therapy in BRCA1 and CHEK2 mutation carriers and non-carriers.
Breast cancer research and treatment 2014 Dec 148 (3): 675-83. Pfeifer Werner, Sokolenko Anna P, Potapova Olga N, Bessonov Alexandr A, Ivantsov Alexandr O, Laptiev Sergey A, Zaitseva Olga A, Yatsuk Olga S, Matsko Dmitry E, Semiglazova Tatiana Yu, Togo Alexandr V, Imyanitov Evgeny |
|
Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.
European journal of human genetics : EJHG 2014 Nov 22 (11): 1305-13. Castéra Laurent, Krieger Sophie, Rousselin Antoine, Legros Angélina, Baumann Jean-Jacques, Bruet Olivia, Brault Baptiste, Fouillet Robin, Goardon Nicolas, Letac Olivier, Baert-Desurmont Stéphanie, Tinat Julie, Bera Odile, Dugast Catherine, Berthet Pascaline, Polycarpe Florence, Layet Valérie, Hardouin Agnes, Frébourg Thierry, Vaur Dominiq |
|
Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer.
Proceedings of the National Academy of Sciences of the United States of America 2014 Oct 111 (42): 15172-7. Kiiski Johanna I, Pelttari Liisa M, Khan Sofia, Freysteinsdottir Edda S, Reynisdottir Inga, Hart Steven N, Shimelis Hermela, Vilske Sara, Kallioniemi Anne, Schleutker Johanna, Leminen Arto, Bützow Ralf, Blomqvist Carl, Barkardottir Rosa B, Couch Fergus J, Aittomäki Kristiina, Nevanlinna He |
|
Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy.
British journal of cancer 2014 Aug 111 (5): 1004-13. Kriege M, Hollestelle A, Jager A, Huijts P E A, Berns E M, Sieuwerts A M, Meijer-van Gelder M E, Collée J M, Devilee P, Hooning M J, Martens J W M, Seynaeve |
Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.
Nature genetics 2014 Jul 46 (7): 736-41. Wang Yufei, McKay James D, Rafnar Thorunn, Wang Zhaoming, Timofeeva Maria N, Broderick Peter, Zong Xuchen, Laplana Marina, Wei Yongyue, Han Younghun, Lloyd Amy, Delahaye-Sourdeix Manon, Chubb Daniel, Gaborieau Valerie, Wheeler William, Chatterjee Nilanjan, Thorleifsson Gudmar, Sulem Patrick, Liu Geoffrey, Kaaks Rudolf, Henrion Marc, Kinnersley Ben, Vallée Maxime, LeCalvez-Kelm Florence, Stevens Victoria L, Gapstur Susan M, Chen Wei V, Zaridze David, Szeszenia-Dabrowska Neonilia, Lissowska Jolanta, Rudnai Peter, Fabianova Eleonora, Mates Dana, Bencko Vladimir, Foretova Lenka, Janout Vladimir, Krokan Hans E, Gabrielsen Maiken Elvestad, Skorpen Frank, Vatten Lars, Njølstad Inger, Chen Chu, Goodman Gary, Benhamou Simone, Vooder Tonu, Välk Kristjan, Nelis Mari, Metspalu Andres, Lener Marcin, Lubi?ski Jan, Johansson Mattias, Vineis Paolo, Agudo Antonio, Clavel-Chapelon Francoise, Bueno-de-Mesquita H Bas, Trichopoulos Dimitrios, Khaw Kay-Tee, Johansson Mikael, Weiderpass Elisabete, Tjønneland Anne, Riboli Elio, Lathrop Mark, Scelo Ghislaine, Albanes Demetrius, Caporaso Neil E, Ye Yuanqing, Gu Jian, Wu Xifeng, Spitz Margaret R, Dienemann Hendrik, Rosenberger Albert, Su Li, Matakidou Athena, Eisen Timothy, Stefansson Kari, Risch Angela, Chanock Stephen J, Christiani David C, Hung Rayjean J, Brennan Paul, Landi Maria Teresa, Houlston Richard S, Amos Christopher |
|
Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations.
Breast cancer research and treatment 2014 Jun 145 (2): 553-62. Sokolenko Anna P, Bogdanova Natalia, Kluzniak Wojciech, Preobrazhenskaya Elena V, Kuligina Ekatherina S, Iyevleva Aglaya G, Aleksakhina Svetlana N, Mitiushkina Natalia V, Gorodnova Tatiana V, Bessonov Alexandr A, Togo Alexandr V, Lubi?ski Jan, Cybulski Cezary, Jakubowska Anna, Dörk Thilo, Imyanitov Evgeny |
|
Variants in the ATM-CHEK2-BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma.
Genes, chromosomes & cancer 2014 Jun 53 (6): 516-23. Wójcicka Anna, Czetwerty?ska Ma?gorzata, ?wierniak Micha?, D?ugosi?ska Joanna, Maci?g Monika, Czajka Agnieszka, Dymecka Kinga, Kubiak Anna, Kot Adam, P?oski Rafa?, de la Chapelle Albert, Ja?d?ewski Krysti |
|
Genetic association of CHEK2, GSTP1, and ERCC1 with glioblastoma in the Han Chinese population.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 May 35 (5): 4937-41. Dong Yu-Shu, Hou Wu-Gang, Li Xiao-Lan, Jin Tian-Bo, Li Yue, Feng Da-Yun, Liu De-Bao, Gao Guo-Dong, Yin Zhong-Min, Qin Huai-Zh |
|
Survival from breast cancer in patients with CHEK2 mutations.
Breast cancer research and treatment 2014 Apr 144 (2): 397-403. Huzarski T, Cybulski C, Wokolorczyk D, Jakubowska A, Byrski T, Gronwald J, Domaga?a P, Szwiec M, Godlewski D, Kilar E, Marczyk E, Sio?ek M, Wi?niowski R, Janiszewska H, Surdyka D, Sibilski R, Sun P, Lubi?ski J, Narod S |
|
Genetic variants associated with colorectal cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence.
Gut 2014 Feb 63 (2): 326-36. Ma Xiangyu, Zhang Ben, Zheng W |
|
Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Feb 20 (3): 764-75. Pennington Kathryn P, Walsh Tom, Harrell Maria I, Lee Ming K, Pennil Christopher C, Rendi Mara H, Thornton Anne, Norquist Barbara M, Casadei Silvia, Nord Alexander S, Agnew Kathy J, Pritchard Colin C, Scroggins Sheena, Garcia Rochelle L, King Mary-Claire, Swisher Elizabeth |
|
CHEK2*1100delC homozygosity in the Netherlands--prevalence and risk of breast and lung cancer.
European journal of human genetics : EJHG 2014 Jan 22 (1): 46-51. Huijts Petra E A, Hollestelle Antoinette, Balliu Brunilda, Houwing-Duistermaat Jeanine J, Meijers Caro M, Blom Jannet C, Ozturk Bahar, Krol-Warmerdam Elly M M, Wijnen Juul, Berns Els M J J, Martens John W M, Seynaeve Caroline, Kiemeney Lambertus A, van der Heijden Henricus F, Tollenaar Rob A E M, Devilee Peter, van Asperen Christi |
|
Identification of two poorly prognosed ovarian carcinoma subtypes associated with CHEK2 germ-line mutation and non-CHEK2 somatic mutation gene signatures.
Cell cycle (Georgetown, Tex.) 2014 13 (14): 2262-80. Ow Ghim Siong, Ivshina Anna V, Fuentes Gloria, Kuznetsov Vladimir |
|
Lack of CHEK2 gene mutations in differentiated thyroid carcinoma patients using high resolution melting analysis.
Asian Pacific journal of cancer prevention : APJCP 2014 15 (12): 5019-22. Fayaz Shima, Fard-Esfahani Pezhman, Torbati Peyman Mohamma |
|
Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study.
Breast cancer research : BCR 2014 16 (3): R58. Damiola Francesca, Pertesi Maroulio, Oliver Javier, Le Calvez-Kelm Florence, Voegele Catherine, Young Erin L, Robinot Nivonirina, Forey Nathalie, Durand Geoffroy, Vallée Maxime P, Tao Kayoko, Roane Terrell C, Williams Gareth J, Hopper John L, Southey Melissa C, Andrulis Irene L, John Esther M, Goldgar David E, Lesueur Fabienne, Tavtigian Sean |
|
Genetic variants in DNA repair pathway genes and risk of esophageal squamous cell carcinoma and gastric adenocarcinoma in a Chinese population.
Carcinogenesis 2013 Jul 34 (7): 1536-42. Li Wen-Qing, Hu Nan, Hyland Paula L, Gao Ying, Wang Zhao-Ming, Yu Kai, Su Hua, Wang Chao-Yu, Wang Le-Min, Chanock Stephen J, Burdett Laurie, Ding Ti, Qiao You-Lin, Fan Jin-Hu, Wang Yuan, Xu Yi, Shi Jian-Xin, Gu Fangyi, Wheeler William, Xiong Xiao-Qin, Giffen Carol, Tucker Margaret A, Dawsey Sanford M, Freedman Neal D, Abnet Christian C, Goldstein Alisa M, Taylor Philip |
|
A personalised approach to prostate cancer screening based on genotyping of risk founder alleles.
British journal of cancer 2013 Jun 108 (12): 2601-9. Cybulski C, Woko?orczyk D, Klu?niak W, Kashyap A, Go??b A, S?ojewski M, Sikorski A, Puszy?ski M, Soczawa M, Borkowski T, Borkowski A, Antczak A, Przyby?a J, Sosnowski M, Ma?kiewicz B, Zdrojowy R, Domaga?a P, Piotrowski K, Menkiszak J, Krzystolik K, Gronwald J, Jakubowska A, Górski B, D?bniak T, Masoj? B, Huzarski T, Muir K R, Lophatananon A, Lubi?ski J, Narod S A, |
|
Haplotype analysis of eight genes of the monoubiquitinated FANCD2-DNA damage-repair pathway in breast cancer patients.
Cancer epidemiology 2013 Jun 37 (3): 311-7. Tang Li-Li, Chen Fei-Yu, Wang Hao, Hu Xue-Li, Dai Xu, Mao Jie, Shen Zheng-Tang, Wu Yu-Hui, Wang Shou-Man, Hai Jian, Yan Guo-Jiao, Li Hui, Huang Ju |
|
The effect of CHEK2 variant I157T on cancer susceptibility: evidence from a meta-analysis.
DNA and cell biology 2013 Jun 32 (6): 329-35. Han Fei-fei, Guo Chang-long, Liu Li-ho |
|
Excess breast cancer risk in first degree relatives of CHEK2?1100delC positive familial breast cancer cases.
European journal of cancer (Oxford, England : 1990) 2013 May 49 (8): 1993-9. Adank Muriel A, Verhoef Senno, Oldenburg Rogier A, Schmidt Marjanka K, Hooning Maartje J, Martens John W M, Broeks Annegien, Rookus Matti, Waisfisz Quinten, Witte Birgit I, Jonker Marianne A, Meijers-Heijboer Han |
|
BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma.
Cancer 2013 Jan 119 (2): 332-8. Pennington Kathryn P, Walsh Tom, Lee Ming, Pennil Christopher, Novetsky Akiva P, Agnew Kathy J, Thornton Anne, Garcia Rochelle, Mutch David, King Mary-Claire, Goodfellow Paul, Swisher Elizabeth |
|
CHK2 1100delC, IVS2+1G>A and I157T mutations are not present in hepatocellular cancer cases from a Turkish population.
Gene 2013 Jan 512 (2): 232-6. Bayram Süleyman, Akk?z Hikmet, Topakta? Mehm |
|
The risk of gastric cancer in carriers of CHEK2 mutations.
Familial cancer 2013 Jan . Teodorczyk U, Cybulski C, Woko?orczyk D, Jakubowska A, Starzy?ska T, Lawniczak M, Domaga?a P, Ferenc K, Marlicz K, Banaszkiewicz Z, Wi?niowski R, Narod SA, Lubi?ski J |
|
Constitutional CHEK2 mutations are infrequent in early-onset and familial breast/ovarian cancer patients from Pakistan.
BMC cancer 2013 13 312. Rashid Muhammad U, Muhammad Noor, Faisal Saima, Amin Asim, Hamann U |
|
Identification of a novel BRCA2 and CHEK2 A-C-G-C haplotype in Turkish patients affected with breast cancer.
Asian Pacific journal of cancer prevention : APJCP 2013 14 (5): 3229-35. Haytural Hazal, Yalcinkaya Nazli, Akan Gokce, Arikan Soykan, Ozkok Elif, Cakmakoglu Bedia, Yaylim Ilhan, Aydin Makbule, Atalar Fatmah |
|
CHEK2 1100DELC germline mutation: a frequency study in hereditary breast and colon cancer Brazilian families.
Arquivos de gastroenterologia 2012 Dec 49 (4): 273-8. Abud Jamile, Prolla João Carlos, |
|
CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Dec 30 (35): 4308-16. Weischer Maren, Nordestgaard Børge G, Pharoah Paul, Bolla Manjeet K, Nevanlinna Heli, Van't Veer Laura J, Garcia-Closas Montserrat, Hopper John L, Hall Per, Andrulis Irene L, Devilee Peter, Fasching Peter A, Anton-Culver Hoda, Lambrechts Diether, Hooning Maartje, Cox Angela, Giles Graham G, Burwinkel Barbara, Lindblom Annika, Couch Fergus J, Mannermaa Arto, Grenaker Alnæs Grethe, John Esther M, Dörk Thilo, Flyger Henrik, Dunning Alison M, Wang Qin, Muranen Taru A, van Hien Richard, Figueroa Jonine, Southey Melissa C, Czene Kamila, Knight Julia A, Tollenaar Rob A E M, Beckmann Matthias W, Ziogas Argyrios, Christiaens Marie-Rose, Collée Johanna Margriet, Reed Malcolm W R, Severi Gianluca, Marme Frederik, Margolin Sara, Olson Janet E, Kosma Veli-Matti, Kristensen Vessela N, Miron Alexander, Bogdanova Natalia, Shah Mitul, Blomqvist Carl, Broeks Annegien, Sherman Mark, Phillips Kelly-Anne, Li Jingmei, Liu Jianjun, Glendon Gord, Seynaeve Caroline, Ekici Arif B, Leunen Karin, Kriege Mieke, Cross Simon S, Baglietto Laura, Sohn Christof, Wang Xianshu, Kataja Vesa, Børresen-Dale Anne-Lise, Meyer Andreas, Easton Douglas F, Schmidt Marjanka K, Bojesen Stig |
|
Identification of a novel in-frame deletion in BRCA2 and analysis of variants of BRCA1/2 in Italian patients affected with hereditary breast and ovarian cancer.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2012 Dec 50 (12): 2171-80. Vietri Maria Teresa, Molinari Anna Maria, Laura De Paola Maria, Cantile Flavia, Fasano Morena, Cioffi Miche |
|
An inherited NBN mutation is associated with poor prognosis prostate cancer.
British journal of cancer 2012 Nov . Cybulski C, Woko?orczyk D, Klu?niak W, Jakubowska A, Górski B, Gronwald J, Huzarski T, Kashyap A, Byrski T, D?bniak T, Go??b A, Gliniewicz B, Sikorski A, Swita?a J, Borkowski T, Borkowski A, Antczak A, Wojnar L, Przyby?a J, Sosnowski M, Ma?kiewicz B, Zdrojowy R, Sikorska-Radek P, Matych J, Wilkosz J, Ró?a?ski W, Ki? J, Bar K, Bryniarski P, Paradysz A, Jersak K, Niemirowicz J, S?upski P, Jarzemski P, Skrzypczyk M, Dobruch J, Domaga?a P, Narod SA, Lubi?ski J |
|
CHEK2 1100delC, IVS2+1G>A and I157T mutations are not present in colorectal cancer cases from Turkish population.
Cancer epidemiology 2012 Oct 36 (5): 453-7. Bayram Süleyman, Topakta? Mehmet, Akk?z Hikmet, Bekar Aynur, Akgöllü Ers |
|
[Prevalence of mutations BRCA1 5382insC, and CHEK2 1100delC in the population of Siberian region].
Genetika 2012 Jun 48 (6): 768-72. Chasovnikova O B, Mitrofanov D V, Anisimenko M S, Voevoda M I, Kovalenko S P, Liakhovich V |
|
Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancer.
Breast cancer research and treatment 2012 Apr 132 (3): 937-45. Domagala Pawel, Wokolorczyk Dominika, Cybulski Cezary, Huzarski Tomasz, Lubinski Jan, Domagala Wenancju |
|
Investigation of the effects of DNA repair gene polymorphisms on the risk of colorectal cancer.
Mutagenesis 2012 Mar 27 (2): 219-23. Tomlinson Ian P M, Houlston Richard S, Montgomery Grant W, Sieber Oliver M, Dunlop Malcolm |
|
CHEK2*1100delC and risk of malignant melanoma: Danish and German studies and meta-analysis.
The Journal of investigative dermatology 2012 Feb 132 (2): 299-303. Weischer Maren, Heerfordt Ida M, Bojesen Stig E, Eigentler Thomas, Garbe Claus, Röcken Martin, Hölmich Lisbet Rosenkrantz, Schmidt Henrik, Klyver Helle, Bastholt Lars, Nordestgaard Børge |
|
Gene-gene interactions in breast cancer susceptibility.
Human molecular genetics 2012 Feb 21 (4): 958-62. Turnbull Clare, Seal Sheila, Renwick Anthony, Warren-Perry Margaret, Hughes Deborah, Elliott Anna, Pernet David, Peock Susan, Adlard Julian W, Barwell Julian, Berg Jonathan, Brady Angela F, Brewer Carole, Brice Glen, Chapman Cyril, Cook Jackie, Davidson Rosemarie, Donaldson Alan, Douglas Fiona, Greenhalgh Lynn, Henderson Alex, Izatt Louise, Kumar Ajith, Lalloo Fiona, Miedzybrodzka Zosia, Morrison Patrick J, Paterson Joan, Porteous Mary, Rogers Mark T, Shanley Susan, Walker Lisa, , Ahmed Munaza, Eccles Diana, Evans D Gareth, Donnelly Peter, Easton Douglas F, Stratton Michael R, Rahman Nazne |
|
Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study.
Human mutation 2012 Jan 33 (1): 158-64. Brooks Jennifer D, Teraoka Sharon N, Reiner Anne S, Satagopan Jaya M, Bernstein Leslie, Thomas Duncan C, Capanu Marinela, Stovall Marilyn, Smith Susan A, Wei Shan, Shore Roy E, Boice John D, Lynch Charles F, Mellemkjaer Lene, Malone Kathleen E, Liang Xiaolin, , Haile Robert W, Concannon Patrick, Bernstein Jonine |
|
[The clinical importance of a genetic analysis of moderate-risk cancer susceptibility genes in breast and other cancer patients from the Czech Republic].
Klinická onkologie : casopis Ceské a Slovenské onkologické spolecnosti 2012 25 Suppl S59-66. Pohlreich P, Kleibl Z, Kleiblová P, Janatová M, Soukupová J, Machá?ková E, Házová J, Vaší?ková P, S?ahlová Hrabincová E, Navrátilová M, Svoboda M, Foretová |
|
CHEK2 1100delC variant and breast cancer risk in Caucasians: a meta-analysis based on 25 studies with 29,154 cases and 37,064 controls.
Asian Pacific journal of cancer prevention : APJCP 2012 13 (7): 3501-5. Yang Yuan, Zhang Fan, Wang Yang, Liu Sheng-Ch |
|
CHEK2 gene alterations independently increase the risk of death from breast cancer in Bulgarian patients.
Neoplasma 2012 59 (6): 622-30. Angelova S G, Krasteva M E, Gospodinova Z I, Georgieva E |
|
Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer.
Breast cancer research : BCR 2012 14 (2): R47. Knappskog Stian, Chrisanthar Ranjan, Løkkevik Erik, Anker Gun, Østenstad Bjørn, Lundgren Steinar, Risberg Terje, Mjaaland Ingvil, Leirvaag Beryl, Miletic Hrvoje, Lønning Per |
|
The CHEK2 I157T variant and breast cancer susceptibility: a systematic review and meta-analysis.
Asian Pacific journal of cancer prevention : APJCP 2012 13 (4): 1355-60. Liu Chuan, Wang Ying, Wang Qing-Shui, Wang Ya-J |
|
The CHEK2 I157T variant and colorectal cancer susceptibility: a systematic review and meta-analysis.
Asian Pacific journal of cancer prevention : APJCP 2012 13 (5): 2051-5. Liu Chuan, Wang Qing-Shui, Wang Ya-J |
|
A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer.
The pharmacogenomics journal 2011 Dec 11 (6): 437-43. Ho-Pun-Cheung A, Assenat E, Bascoul-Mollevi C, Bibeau F, Boissière-Michot F, Thezenas S, Cellier D, Azria D, Rouanet P, Senesse P, Ychou M, Lopez-Crapez |
|
CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women.
Journal of medical genetics 2011 Dec 48 (12): 860-3. Adank Muriel A, Jonker Marianne A, Kluijt Irma, van Mil Saskia E, Oldenburg Rogier A, Mooi Wolter J, Hogervorst Frans B L, van den Ouweland Ans M W, Gille Johan J P, Schmidt Marjanka K, van der Vaart Aad W, Meijers-Heijboer Hanne, Waisfisz Quint |
|
Variant allele of CHEK2 is associated with a decreased risk of esophageal cancer lymph node metastasis in a Chinese population.
Molecular biology reports 2011 Dec . Gu H, Qiu W, Wan Y, Ding G, Tang W, Liu C, Shi Y, Chen Y, Chen S |
|
Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibility.
European journal of cancer (Oxford, England : 1990) 2011 Nov 47 (17): 2546-51. Xiang He-ping, Geng Xiao-ping, Ge Wei-wei, Li |
|
Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Oct 29 (28): 3747-52. Cybulski Cezary, Woko?orczyk Dominika, Jakubowska Anna, Huzarski Tomasz, Byrski Tomasz, Gronwald Jacek, Masoj? Bart?omiej, Deebniak Tadeusz, Górski Bohdan, Blecharz Pawe?, Narod Steven A, Lubi?ski J |
|
A recurrent CHEK2 p.H371Y mutation is associated with breast cancer risk in Chinese women.
Human mutation 2011 Sep 32 (9): 1000-3. Liu Yin, Liao Ji, Xu Ye, Chen Weiqiu, Liu Dongyun, Ouyang Tao, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Lin Benyao, Xu Xingzhi, Xie Yunt |
|
CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer risk.
Twin research and human genetics : the official journal of the International Society for Twin Studies 2011 Aug 14 (4): 328-32. O'Mara Tracy A, Ferguson Kaltin, Fahey Paul, Marquart Louise, Yang Hannah P, Lissowska Jolanta, Chanock Stephen, Garcia-Closas Montserrat, Thompson Deborah J, Healey Catherine S, Dunning Alison M, Easton Douglas F, , Webb Penelope M, Spurdle Amanda |
|
Associations between polymorphisms in DNA repair genes and TP53 mutations in non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2011 Jul 73 (1): 25-31. Cho Sukki, Kim Min Jung, Choi Yi Young, Yoo Seung Soo, Lee Won Kee, Lee Eun Jin, Jang Eun Jeong, Bae Eun Young, Jin Guang, Jeon Hyo-Sung, Lee Shin Yup, Cha Sung-Ick, Park Tae In, Kim Chang Ho, Park Jae Yo |
|
DNA repair gene polymorphisms and tobacco smoking in the risk for colorectal adenomas.
Carcinogenesis 2011 Jun 32 (6): 882-7. Gao Ying, Hayes Richard B, Huang Wen-Yi, Caporaso Neil E, Burdette Laurie, Yeager Meredith, Chanock Stephen J, Berndt Sonja |
|
Irrelevance of CHEK2 variants to diagnosis of breast/ovarian cancer predisposition in Polish cohort.
Journal of applied genetics 2011 May 52 (2): 185-91. Myszka Aleksander, Karpinski Pawel, Slezak Ryszard, Czemarmazowicz Halina, Stembalska Agnieszka, Gil Justyna, Laczmanska Izabela, Bednarczyk Damian, Szmida Elzbieta, Sasiadek Maria Malgorza |
|
Comprehensive pathway-based association study of DNA repair gene variants and the risk of nasopharyngeal carcinoma.
Cancer research 2011 Apr 71 (8): 3000-8. Qin Hai-De, Shugart Yin Yao, Bei Jin-Xin, Pan Qing-Hua, Chen Lina, Feng Qi-Sheng, Chen Li-Zhen, Huang Wei, Liu Jian Jun, Jorgensen Timothy J, Zeng Yi-Xin, Jia Wei-H |
|
Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes.
Neurology 2011 Mar 76 (12): 1059-65. Hasan S K, Buttari F, Ottone T, Voso M T, Hohaus S, Marasco E, Mantovani V, Garagnani P, Sanz M A, Cicconi L, Bernardi G, Centonze D, Lo-Coco |
|
Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk.
Breast cancer research and treatment 2011 Jan 125 (1): 207-14. Monsees Genevieve M, Kraft Peter, Chanock Stephen J, Hunter David J, Han Jia |
|
Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).
PloS one 2011 6 (2): e16914. Campa Daniele, Hüsing Anika, Stein Angelika, Dostal Lucie, Boeing Heiner, Pischon Tobias, Tjønneland Anne, Roswall Nina, Overvad Kim, Østergaard Jane Nautrup, Rodríguez Laudina, Sala Núria, Sánchez Maria-José, Larrañaga Nerea, Huerta José María, Barricarte Aurelio, Khaw Kay-Tee, Wareham Nicholas, Travis Ruth C, Allen Naomi E, Lagiou Pagona, Trichopoulou Antonia, Trichopoulos Dimitrios, Palli Domenico, Sieri Sabina, Tumino Rosario, Sacerdote Carlotta, van Kranen Henk, Bueno-de-Mesquita H Bas, Hallmans Göran, Johansson Mattias, Romieu Isabelle, Jenab Mazda, Cox David G, Siddiq Afshan, Riboli Elio, Canzian Federico, Kaaks Rudo |
|
Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel.
PloS one 2011 6 (4): e19249. Chrisanthar Ranjan, Knappskog Stian, Løkkevik Erik, Anker Gun, Ostenstad Bjørn, Lundgren Steinar, Risberg Terje, Mjaaland Ingvil, Skjønsberg Gudbrand, Aas Turid, Schlichting Ellen, Fjösne Hans E, Nysted Arne, Lillehaug Johan Richard, Lønning Per Eyste |
|
Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study.
Breast cancer research : BCR 2011 13 (1): R6. Le Calvez-Kelm Florence, Lesueur Fabienne, Damiola Francesca, Vallée Maxime, Voegele Catherine, Babikyan Davit, Durand Geoffroy, Forey Nathalie, McKay-Chopin Sandrine, Robinot Nivonirina, Nguyen-Dumont Tù, Thomas Alun, Byrnes Graham B, , Hopper John L, Southey Melissa C, Andrulis Irene L, John Esther M, Tavtigian Sean |
|
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Breast cancer research : BCR 2011 13 (1): R20. Kuusisto Kirsi M, Bebel Aleksandra, Vihinen Mauno, Schleutker Johanna, Sallinen Satu-Lee |
- Page last reviewed:Mar 1, 2018
- Page last updated:Jul 11, 2019
- Content source: